Atlas Trials

Immunoregulatory Effect of Microparticle Delivered STING Agonist in the Control of Experimental Autoimmune Encephalomyelitis (EAE) and Multiple Sclerosis (MS)

Clinical trial NCT05705986 · UNKNOWN

Trial details

NCT number
NCT05705986
Sponsor
Thomas Jefferson University
Status
UNKNOWN
Study type
OBSERVATIONAL
Relapse Remitting Multiple Sclerosis
Start date
2021-02-26
Primary completion
2024-05-01
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.